Citation Impact
Citing Papers
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Development and validation of the Nancy histological index for UC
2015 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
The clinician’s guide to prevention and treatment of osteoporosis
2022
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
UK clinical guideline for the prevention and treatment of osteoporosis
2017
Glucocorticoid-Induced Osteoporosis: Summary of a Workshop
2001
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials
2013 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography
2004
Randomized Placebo-Controlled Trial of Androgen Effects on Muscle and Bone in Men Requiring Long-Term Systemic Glucocorticoid Treatment
2003
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study
2018
The Effect of Anti‐TNF‐α Therapy on Spinal Bone Mineral Density in Patients with Crohn's Disease
2006
A Controlled Study of Vitamin D3 to Prevent Bone Loss in Renal-Transplant Patients Receiving Low Doses of Steroids
2004
Cystic fibrosis
2016 Standout
Relationship between age, renal function and bone mineral density in the US population
2003
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis
2007
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Osteoarthritis: A disease of the joint as an organ
2012 Standout
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
2017
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Vitamin D Deficiency
2007 Standout
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
Pharmacology of bisphosphonates
2011
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Osteoporosis: now and the future
2011 Standout
Osteoarthritis
2015 Standout
Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis
2000
Multicentre trial of weekly risedronate on bone density in adults with cystic fibrosis
2011
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
2013 Standout
Glucocorticoid-induced Osteoporosis
2000
A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease
2007
Skeletal remodeling in health and disease
2007 Standout
Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
2010 Standout
Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment
2004
The Epidemiology of Distal Radius Fractures
2012 Standout
Review article: defining remission in ulcerative colitis
2011
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD)
2006
Current options for the management of postmenopausal osteoporosis
2011
AGA technical review on osteoporosis in gastrointestinal diseases
2003
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy
2003
Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
2007
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
2009
Bisphosphonate-Induced Hypocalcemia: Report of 3 Cases and Review of Literature
2006
Transdermal delivery of drugs for the treatment of bone diseases
2000
American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
2010
Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice
2012
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two‐year multinational knee osteoarthritis structural arthritis study
2006
Risedronate Rapidly Reduces the Risk for Nonvertebral Fractures in Women with Postmenopausal Osteoporosis
2004
Towards a diagnostic and therapeutic consensus in male osteoporosis
2011
Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients
2000
Effects of teriparatide versus alendronate for treating glucocorticoid‐induced osteoporosis: Thirty‐six–month results of a randomized, double‐blind, controlled trial
2009
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids
2002
Management of Crohn's Disease in Adults
2009 Standout
COPD and Osteoporosis
2002
Bisphosphonate treatment of osteoporosis
2003
Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies
2004
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids
2002
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
American Association Of Clinical Endocrinologists, Associazione Medici Endocrinologi, And European Thyroid Association Medical Guidelines For Clinical Practice For The Diagnosis And Management Of Thyroid Nodules
2010 Standout
Effect of 6-Month Whole Body Vibration Training on Hip Density, Muscle Strength, and Postural Control in Postmenopausal Women: A Randomized Controlled Pilot Study
2004 Standout
Italian guidelines for the diagnosis and treatment of Paget’s disease of bone
2011
Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs.
2001
Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005–2025
2006 Standout
Osteoporosis in Men
2008
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
2008
Risk factors for osteoporosis in female patients with systemic lupus erythematosus
2004
Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta‐Analysis
2016
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery Medical Guidelines for Clinical Practice for the Perioperative Nutritional, Metabolic, and Nonsurgical Support of the Bariatric Surgery Patient
2008
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
2012
Disorders of balance and vestibular function in US adults: data from the National Health and Nutrition Examination Survey, 2001-2004.
2009 Standout
Strategies for balance rehabilitation: fall risk and treatment.
2001
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Addressing unmeasured confounding in comparative observational research
2018 StandoutNobel
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Long-Term Treatment of Incadronate Disodium Accumulates Microdamage but Improves the Trabecular Bone Microarchitecture in Dog Vertebra
2003
Bisphosphonates for steroid-induced osteoporosis
2016
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Safety and Efficacy of Risedronate in Patients With Age-Related Reduced Renal Function as Estimated by the Cockcroft and Gault Method: A Pooled Analysis of Nine Clinical Trials
2005
Works of Rachelle Eusebio being referenced
Evidence for safety and efficacy of risedronate in men with osteoporosis over 4 years of treatment: Results from the 2-year, open-label, extension study of a 2-year, randomized, double-blind, placebo-controlled study
2012
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results
2007
A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data
2012
Improvement of pagetic bone lesions with risedronate treatment: a radiologic study
2000
Paget’s Disease of Bone: Reduction of Disease Activity With Oral Risedronate
1998
Effect of renal function on risedronate pharmacokinetics after a single oral dose
2000
Risedronate Gastrointestinal Absorption Is Independent of Site and Rate of Administration
1998
Risedronate Pharmacokinetics and Intra- and Inter-Subject Variability Upon Single-Dose Intravenous and Oral Administration
2001
Efficacy and Safety of Daily Risedronate in the Treatment of Corticosteroid-Induced Osteoporosis in Men and Women: A Randomized Trial
2000
Different definitions of remission for ulcerative colitis result in large variations of clinical outcome scores
2007
Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
2008
Risedronate in the Treatment of Paget's Disease of Bone: An Open Label, Multicenter Study
1998